# Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain

> **NCT05610813** · PHASE3 · COMPLETED · sponsor: **Vertanical GmbH** · enrollment: 384 (actual)

## Conditions studied

- Chronic Non-specific Low Back Pain

## Interventions

- **DRUG:** VER-01
- **DRUG:** Opioid therapy

## Key facts

- **NCT ID:** NCT05610813
- **Lead sponsor:** Vertanical GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-08
- **Primary completion:** 2024-10-18
- **Final completion:** 2024-10-18
- **Target enrollment:** 384 (ACTUAL)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05610813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05610813, "Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05610813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*